19.09.2019
- French drugmaker Sanofi and US pharma and medical devices company Abbott Laboratories have teamed up to integrate glucose sensing and insulin delivery technologies, with the aim of...
27.04.2017
- Bioelectronic technologies for modulating the signaling capabilities of the nervous system could pose challenges for producers of medicinal materials and chemicals – but also for...
21.09.2016
- In a push to expand its eye care business, Johnson & Johnson (J&J) has agreed to pay nearly $4.33 billion in cash to buy Abbott Medical Optics (AMO), a wholly-owned subsidiary of...
15.02.2016
- On the rebound from its failed $27 billion hostile bid for Perrigo, Netherlands-domiciled, US-managed drugmaker Mylan has announced it will acquire Sweden’s Meda for 83.6 billion...
08.06.2015
- Recipharm has appointed Jean-François Hilaire to the new position of Chief Strategy Officer with effect from June 1, 2015. Hilaire is a pharmacist and graduated from the University...
24.04.2015
- US-managed generics drugmaker Mylan, now domiciled in the Netherlands, is said to be preparing a "poison pill" defense to escape its pursuit by Israeli generics giant Teva. Teva...
12.08.2014
- US generic drugmaker Mylan has shaved the top end of its full-year revenue and earnings forecasts slightly, citing delays in approval from the US Food and Drug Administration for...
21.07.2014
- In its fifth attempt to buy the company, AbbVie, a recent spin-off of US drugmaker Abbott Laboratories, has won the race to acquire European rival Shire, clinching the deal for...
